Diffuse Large B-cell Lymphoma (DLBCL), Cardiotoxicity, Lymphoma
Location: Boston MA
Sponsor: Beth Israel Deaconess Medical Center
Sex: All
Age: 18+
Code: NCT07654426
Phase2, Recruiting
Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05672251
Phase2, Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
for
Lymphoma, Non-Hodgkin, Lymphoma, Follicular,
Location: Toronto, Nashville TN, Denver CO
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07519772
Phase1, Phase2, Recruiting
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
for
Acute Adult T-Cell Leukemia/Lymphoma,
Location: Commack NY, Uniondale NY, Mineola NY, Harrison NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04301076
Phase1, Recruiting
Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
for
Recurrent Plasmablastic Lymphoma,
Location: Pittsburgh PA, Duarte CA, Orange CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07332507
Phase1, Recruiting
Interested in new lymphoma trials?
Get alerts for new trials in your area by subscribing now
Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
for
T-cell Acute Lymphoblastic Leukemia, Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 12 - 30
Code: NCT07513129
Phase1, Recruiting
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
for
Chronic Lymphocytic Leukemia (CLL),
Location: Boston MA, Durham NC, Winston-Salem NC, Charlotte NC
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07024706
Phase2, Recruiting
Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cell Transplant: A Pilot Study
for
Lymphoma Receiving CAR-T Therapy
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT07509450
Recruiting
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
for
Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma,
Location: Nashville TN, Iowa City IA, Dallas TX, Fullerton CA,
Sponsor: TORL Biotherapeutics, LLC
Sex: All
Age: 18+
Code: NCT07439653
Phase1, Phase2, Recruiting
A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
for
Diffuse Large B Cell Lymphoma Refractory,
Location: Lexington KY
Sponsor: Pierluigi Porcu
Sex: All
Age: 18+
Code: NCT06789159
Phase1, Recruiting
Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma
for
Recurrent B Acute Lymphoblastic Leukemia,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT07532525
Phase1, Recruiting
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
for
Folliculotropic Mycosis Fungoides,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT03011814
Phase1, Phase2, Recruiting
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Location: New York NY, Jacksonville FL, Mobile AL, Coon Rapids MN
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07218341
Recruiting
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL
for
Anaplastic Large Cell Lymphoma, ALK-Positive
Location: Valhalla NY
Sponsor: New York Medical College
Sex: All
Age: 1 - 39
Code: NCT07013565
Phase2, Recruiting
Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
for
Follicular Helper T-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07278856
Phase1, Recruiting
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
for
Diffuse Large B-cell Lymphoma (DLBCL)
Location: Boston MA, Stony Brook NY, New Brunswick NJ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06091865
Phase3, Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Boston MA, New York NY, Rochester NY, Miami FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07226843
Phase1, Recruiting
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
for
Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma,
Location: Fort Wayne IN
Sponsor: Grifols Biologicals, LLC
Sex: All
Age: 18+
Code: NCT07582432
Phase3, Recruiting
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
for
Relapsed or Refractory Large B-cell Lymphoma
Location: New Haven CT, Quebec, New York NY, Montreal,